The Enterprise Value as of December 2025 (TTM) for Citius Oncology, Inc. (CTOR) is 96.50M

According to Citius Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 96.50M. This represents a change of -32.84% compared to the average of 143.68M of the last 4 quarters.

Citius Oncology, Inc. (CTOR) Historical Enterprise Value (quarterly & annually)

How has CTOR Enterprise Value performed in the past?

The mean historical Enterprise Value of Citius Oncology, Inc. over the last ten years is 539.06M. The current 96.50M Enterprise Value has changed 1.69% with respect to the historical average. Over the past ten years (40 quarters), CTOR's Enterprise Value was at its highest in in the December 2022 quarter at 1.03B. The Enterprise Value was at its lowest in in the April 2021 quarter at 0.

Citius Oncology, Inc. (CTOR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Citius Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Citius Oncology, Inc. (CTOR) Average Enterprise Value

How has CTOR Enterprise Value performed in the past?

The current Enterprise Value of Citius Oncology, Inc. (CTOR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Citius Oncology, Inc. (CTOR) Enterprise Value vs. Peers

How is CTOR’s Enterprise Value compared to its peers?

Citius Oncology, Inc.’s Enterprise Value is less than Scilex Holding Company (212.22M), less than Actuate Therapeutics Inc (153.91M), less than Forte Biosciences, Inc. (164.14M), greater than Spero Therapeutics, Inc. (83.18M), greater than Applied Therapeutics, Inc. (23.64M), greater than Vor Biopharma Inc. (-100309963.00), less than Seres Therapeutics, Inc. (194.69M), less than Fate Therapeutics, Inc. (165.48M), less than LENSAR, Inc. (131.23M), less than Owlet, Inc. (216.84M),

Build a custom stock screener for Citius Oncology, Inc. (CTOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Citius Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Citius Oncology, Inc. (CTOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Citius Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.